TY - JOUR AU - PAHWA, RAKESH AU - BHARDWAJ, BIGUL YOGESHVER AU - SHARMA, ARCHANA AU - PIPLANI, MONA AU - KUMAR, MANISH PY - 2021/05/07 Y2 - 2024/03/29 TI - GASTRORETENTIVE FLOATING TECHNOLOGY FOR ERADICATION OF HELICOBACTER PYLORI: AN INSIGHT VIEW JF - International Journal of Applied Pharmaceutics JA - Int J App Pharm VL - 13 IS - 3 SE - Review Article(s) DO - 10.22159/ijap.2021v13i3.39369 UR - https://journals.innovareacademics.in/index.php/ijap/article/view/39369 SP - 5-10 AB - <p><em>Helicobacter pylori </em>is a virulent human pathogen infecting about 50% of the population worldwide. Being a leading cause of gastric ulcer, duodenal ulcer, gastritis, dyspepsia, gastric tumorigenesis etc., this organism has been the focus of concerted study to establish uncertainty of its genetics, immunopathogenesis and cell biology. Scientists have tried to effectively eradicate this pathogen from the gastrointestinal tract in various manners. Inquest of this venture, gastroretentive drug delivery systems including floating dosage forms have emerged as a boon and offer significantly improved therapeutic effects of different antimicrobial drugs. This article presents an evocative review of the structural features, epidemiological evidences and various pharmacotherapeutics vistas. In addition, various novel gastroretentive dosage forms developed so far to combat <em>Helicobacter pylori</em> infection are also discussed. Comprehensive literature review has been performed for this manuscript by utilizing relevant databases like PubMed, SCOPUS, Web of Science, Science Direct, Google Scholar etc., from 1997 up to the year 2020.</p> ER -